AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Importance of Infrastructure for Clinical Trials in India
There are very few in investigator initiated trials. The reason is because of very stringent rules that have been laid down by the regulatory authorities. A hematologist in India, I see AML. I also see thalassemia, emophilia, ITP, autoimmune,. He doesn't think we have dedicated time to do focus research and clinical trial. On top of that, we do not have infrastructure basically to conduct phase one or phase two trials.